Cost-effectiveness analysis of an innovative model of care for chronic wounds patients

David Brain, Ruth Tulleners, Xing Lee, Qinglu Cheng, Nicholas Graves, Rosana Pacella, David Brain, Ruth Tulleners, Xing Lee, Qinglu Cheng, Nicholas Graves, Rosana Pacella

Abstract

Current provision of services for the care of chronic wounds in Australia is disjointed and costly. There is large variability in the way that services are provided, and little evidence regarding the cost-effectiveness of a specialist model of care for treatment and management. A decision-analytic model to evaluate the cost-effectiveness of a specialist wound care clinic as compared to usual care for chronic wounds is presented. We use retrospective and prospective data from a cohort of patients as well as information from administrative databases and published literature. Our results show specialist wound clinics are cost-effective for the management of chronic wounds. On average, specialist clinics were $3,947 cheaper than usual clinics and resulted in a quality adjusted life year gain of 0.04 per patient, per year. Specialist clinics were the best option under multiple scenarios including a different cost perspective and when the cost of a hospital admission was reduced. Current models of care are inefficient and represent low value care, and specialist wound clinics represent a good investment compared to current approaches for the management of chronic wounds in Australia.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1. Pictorial representation of the Markov…
Fig 1. Pictorial representation of the Markov model used for economic evaluation of specialist wound care clinic.
Fig 2. Probability that specialist clinics are…
Fig 2. Probability that specialist clinics are cost-effective for a range of willingness to pay thresholds.

References

    1. Edwards H, Finlayson K, Courtney M, Graves N, Gibb M, Parker C. Health service pathways for patients with chronic leg ulcers: identifying effective pathways for facilitation of evidence based wound care. BMC Health Services Research 2013;13(1):86.
    1. Graves N, Finlayson K, Gibb M, O’Reilly M, Edwards H. Modelling the economic benefits of gold standard care for chronic wounds in a community setting. Wound Practice & Research: Journal of the Australian Wound Management Association. 2014;22(3):163–8.
    1. KPMG Commissioned by Australian Wound Management Association. An economic evaluation of compression therapy for venous leg ulcers 2013 [.
    1. Health National and Medical Research Council N. National evidence-based guideline: Prevention, identification and management of foot complications in diabetes (Part of the guidelines on management of type 2 diabetes). Melbourne: Baker IDI Heart & Diabetes Institute; 2011. [.
    1. Kruger A, Raptis S, Fitridge R. Management practices of Australian surgeons in the treatment of venous ulcers. ANZ Journal of Surgery. 2003;73(9):687–91.
    1. Woodward M. Wound management by aged care specialists. Prim Intention. 2002;10:70.
    1. Norman R, Gibb M, Dyer A, Prentice J, Yelland S, Cheng Q, et al. Improved wound management at lower cost: A sensible goal for Australia. International Wound Journal. 2016;13(3):303–16. 10.1111/iwj.12538
    1. Baker SR & Stacey MC. Epidemiology of chronic leg ulcers in Australia. ANZ Journal of Surgery. 1994: 64(4): 258–261.
    1. Sun X, Ni P, Wu M, Huang Y, Ye J, Xie T. A Clinicoepidemiological Profile of Chronic Wounds in Wound Healing Department in Shanghai. The International Journal of Lower Extremity Wounds. 2017;16(1):36–44. 10.1177/1534734617696730
    1. Rondas AA, Schols JM, Halfens RJ, Hull HR, Stobberingh EE & Evers SM. Cost analysis of one of the first outpatient wound clinics in the Netherlands. J Wound Care. 2015;24(9):426–36. 10.12968/jowc.2015.24.9.426
    1. Le Goff-Pronost M, Mourgeon B, Blanchere JP, Teot L, Benateau H & Dompmartin A. Real-World Clinical Evaluation and Costs of Telemedicine for Chronic Wound Management. International journal of technology assessment in health care. 2018:1–9.
    1. Cheng Q, Lazzarini PA, Gibb M, Derhy PH, Kinnear EM, Burn E, et al. A cost‐effectiveness analysis of optimal care for diabetic foot ulcers in Australia. International Wound Journal. 2017;14(4):616–28. 10.1111/iwj.12653
    1. Cheng Q, Gibb M, Graves N, Finlayson K & Pacella R. Cost-effectiveness analysis of guideline-based optimal care for venous leg ulcers in Australia. BMC Health Services Research. 2018:18:421 10.1186/s12913-018-3234-3
    1. Husereau D, Drummond M, Petrou S, Caswell C, Moher D, Greenberg D, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. British Medical Journal. 2013; 346:f1049 10.1136/bmj.f1049
    1. Innes-Walker K, Edwards H. A wound management education and training needs analysis of health consumers and the relevant health workforce and stocktake of available education and training activities and resources. Wound Practice and Research. 2013;21(3):104–9.
    1. Pacella R, Tulleners R, Cheng Q, Burkett E, Edwards H, Yelland S, et al. Solutions to the Chronic Wounds Problem in Australia: A Call to Action. Wound Practice and Research. 2018; 26(2): p.84–98 2018.
    1. Tulleners R, Brain D, Lee X, Cheng Q, Graves N & Pacella RE. Health benefits of an innovative model of care for chronic wounds patients in Queensland. In Press: International Wound Journal. 2018
    1. Briggs A & Sculpher M. An introduction to Markov modelling for economic evaluation.Pharmacoeconomics 1998, 13(4):397–409. 10.2165/00019053-199813040-00003
    1. Pharmaceutical Benefits Advisory Committee. Guidelines for preparing submissions to the Pharmaceutical Benefits Advisory Committee. Canberra: Pharmaceutical Benefits Advisory Committee, 2013.
    1. Briggs A, Claxton K & Sculpher M. Decision modelling for health economic evaluation. Oxford University Press, Oxford, 2006.
    1. Australian Bureau of Statistics. 2018.
    1. Iversen MM, Tell GS, Riise T, Hanestad BR, Ostbye T, Graue M, et al. History of foot ulcer increases mortality among individuals with diabetes. Diabetes Care. 2009: 32(12): 2193–2199. 10.2337/dc09-0651
    1. Drummond M, Sculpher M, Claxton K, Stoddart GL & Torrance GW. Methods for the economic evaluation of health care programmes (4th ed). Oxford University Press, Oxford, 2015.
    1. Iglesias CP, Birks Y, Nelson EA, Scanlon E, Cullum NA. Quality of life of people with venous leg ulcers: a comparison of the discriminative and responsive characteristics of two generic and a disease specific instruments. Qual Life Res 2005, 14(7):1705–1718.
    1. NICE guideline—Chronic Heart Failure: National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care: Partial Update. London: National Clinical Guideline Centre; 2010.
    1. Graves N, Birrell FA, Whitby M. Modeling the economic losses from pressure ulcers among hospitalised patients in Australia. Wound Repair and Regeneration. 2005;13:462–7. 10.1111/j.1067-1927.2005.00066.x
    1. Drummond M, McGuire A. Economic evaluation in health care: merging theory with practice. New York: Oxford University Press, 2001.
    1. Shiroiwa T, Sung YK, Fukuda T, Lang HC, Bae SC, Tsutani K: International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? Health Econ 2010, 19:422–437. 10.1002/hec.1481
    1. Stinnett A, & Mullahy J. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Medical Decision Making, 1998. 18(S68-S80).
    1. Page K, Barnett AG & Graves N. What is a hospital bed day worth? A contingent valuation study of hospital Chief Executive Officers. BMC Health Services Research. 2017; 17:137 10.1186/s12913-017-2079-5
    1. Australian Wound Management Association and the New Zealand Wound Care Society. Australian and New Zealand Clinical Practice Guideline for Prevention and Management of Venous Leg Ulcers. Cambridge Publishing; 2011.
    1. Hicks CW, Selvarajah S, Mathioudakis N, Sherman RE, Hines KF, Black JH, et al. Burden of Infected Diabetic Foot Ulcers on Hospital Admissions and Costs. Annals of vascular surgery. 2016;33:149–58. 10.1016/j.avsg.2015.11.025
    1. Graves N, Zheng H. Modelling the direct health care costs of chronic wounds in Australia. Wound Practice and Research. 2014; 22(1):20–4, p. 6–33.
    1. Harris AD, McGregor JC, Perencevich EN, Furuno JP, Zhu J, Peterson DE, et al. The use and interpretation of quasi-experimental studies in medical informatics. Journal of the American Medical Informatics Association. 2006; 13(1): 16–23. 10.1197/jamia.M1749

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi